Konstantinos Rounis

Publications
Public outreach and news

Articles

Article: PLOS ONE. 2023;18(2):e0277708
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
Makrakis D; Rounis K; Tsigkas A-P; Georgiou A; Galanakis N; Tsakonas G; Ekman S; Papadaki C; Monastirioti A; Kontogianni M; Gioulbasanis I; Mavroudis D; Agelaki S
Article: CANCERS. 2022;14(19):4739
Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab
Monastirioti A; Papadaki C; Kalapanida D; Rounis K; Michaelidou K; Papadaki MA; Mavroudis D; Agelaki S
Article: CELLS. 2021;10(8):1988
A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer.
Monastirioti A; Papadaki C; Rounis K; Kalapanida D; Mavroudis D; Agelaki S
Article: TRANSLATIONAL LUNG CANCER RESEARCH. 2021;10(8):3538-3549
Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study.
Rounis K; Makrakis D; Tsigkas A-P; Georgiou A; Galanakis N; Papadaki C; Monastirioti A; Vamvakas L; Kalbakis K; Vardakis N; Kontogianni M; Gioulbasanis I; Mavroudis D; Agelaki S
Article: CANCERS. 2021;13(13):3151
High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC
Tsakonas G; Martin-Bernabe A; Rounis K; Moreno-Ruiz P; Botling J; De Petris L; Ylipaa A; Mezheyeuski A; Micke P; Ostman A; Ekman S
Article: BIOMEDICINES. 2021;9(4):421
MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer.
Papadaki C; Thomopoulou K; Monastirioti A; Koronakis G; Papadaki MA; Rounis K; Vamvakas L; Nikolaou C; Mavroudis D; Agelaki S
Article: CANCERS. 2021;13(7):1562
Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy
Rounis K; Skribek M; Makrakis D; De Petris L; Agelaki S; Ekman S; Tsakonas G
Article: EUROPEAN JOURNAL OF CANCER. 2021;145:245-254
Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors
Skribek M; Rounis K; Afshar S; Grundberg O; Friesland S; Tsakonas G; Ekman S; De Petris L
Article: CANCER MANAGEMENT AND RESEARCH. 2021;13:8257-8271
Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy.
Kachris S; Papadaki C; Rounis K; Tsitoura E; Kokkinaki C; Nikolaou C; Sourvinos G; Mavroudis D
Article: PLOS ONE. 2021;16(6):e0252537
Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
Rounis K; Makrakis D; Papadaki C; Monastirioti A; Vamvakas L; Kalbakis K; Gourlia K; Xanthopoulos I; Tsamardinos I; Mavroudis D; Agelaki S
Article: CANCERS. 2020;12(12):E3707-3707
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting
Skribek M; Rounis K; Makrakis D; Agelaki S; Mavroudis D; De Petris L; Ekman S; Tsakonas G
Article: CANCERS. 2020;12(6):E1556-1556
Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy.
Papadaki MA; Sotiriou AI; Vasilopoulou C; Filika M; Aggouraki D; Tsoulfas PG; Apostolopoulou CA; Rounis K; Mavroudis D; Agelaki S
Article: CANCERS. 2020;12(5):E1282-1282
Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy.
Papadaki C; Monastirioti A; Rounis K; Makrakis D; Kalbakis K; Nikolaou C; Mavroudis D; Agelaki S

All other publications

Review: LIFE-BASEL. 2022;12(6):880
Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies
Rounis K; Makrakis D; Gioulbasanis I; Ekman S; De Petris L; Mavroudis D; Agelaki S
Review: JOURNAL OF INTERNAL MEDICINE. 2022;291(6):732-754
Complications following novel therapies for non-small cell lung cancer
Skribek M; Rounis K; Tsakonas G; Ekman S
Review: LUNG CANCER. 2019;135:29-32
Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review.
Konstantina T; Konstantinos R; Anastasios K; Anastasia M; Eleni L; Ioannis S; Sofia A; Dimitris M
Editorial comment: TRANSLATIONAL CANCER RESEARCH. 2019;8(Suppl 2):s99-s102
A new paradox for pCR in BRCA mutation carriers.
Rounis K; Mavroudis D

Articles

All other publications

News from KI

Events from KI